Neena's disease slipped into a life-threatening stage even after two cycles of chemotherapy. She did not have a human leukocyte antigen, or HLA matched donor for a stem cell transplant, the standard procedure for such situations.
This prompted a team of specialists led by Dr Neeraj Sidharth, Head of Bone and Marrow Transplant programme at Amrita hospital, to try 'microtransplant', "a relatively new treatment protocol", for the first time in the country, a hospital release said.
The result was "a success and Neena can possibly spring back to her normal life", though long-term data on a larger number of patients was required to validate the medical procedure, the release said.
"What we attempted was similar to what has been already tried in Israel and China and published in reputed science journals," said Dr Sidharth, who was guided by experts in the field from John Hopkins Hospital, Baltimore, United States and from China.
Unlike normal treatment for acute blood cancer, this procedure does not require heavy dose of chemotherapy. Microtransplant is cost effective - one fifth of the cost of standard treatment available and the patient needed to be hospitalised for just three weeks, he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
